Lv61
3140 积分 2024-05-21 加入
TNFR2: A Novel Target for Cancer Immunotherapy
34分钟前
待确认
Structural basis for the catalytic mechanism of human lipid phosphate phosphatases
2个月前
已完结
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
2个月前
已完结
JMB2403, a potential best-in-class PD-1-dependent IL2Rβγ-activating tri-specific antibody for safe and potent immunotherapy
3个月前
已完结
Exploring the next generation of antibody–drug conjugates
3个月前
已完结
Recent advances in function-enhanced antibody-drug conjugates: Antibody optimization and payload combination
3个月前
已完结
Reduction of monoclonal antibody viscosity using interpretable machine learning
3个月前
已完结
A bispecific nanobody-drug conjugate targeting TROP2 and c-Met for low-concentration, single-dose treatment of pancreatic cancer
3个月前
已完结
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
4个月前
已完结
‘Anticalins’: a new class of engineered ligand-binding proteins with antibody-like properties
4个月前
已完结